Compare ADMA Biologics Inc (ADMA) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs NRG Energy Inc — how do they compare? ADMA Biologics Inc trades at $9.1 (market cap $2.04B), while NRG Energy Inc trades at $103.85 (market cap $21.79B). The key difference: NRG Energy Inc is far larger — about 10.7× ADMA Biologics Inc's market cap, and NRG Energy Inc pays a 1.83% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold ADMA Biologics Inc for 18 Days and NRG Energy Inc for 63 Days on average.
| ADMA | NRG | |
|---|---|---|
Market Cap | $2.04B | $21.79B |
Volume | 11,401,381 | 3,690,567 |
Sector | Health | Utilities |
52-Week High | $20.38 | $184.03 |
52-Week Low | $7.60 | $103.66 |
Typical Hold Time | 18 Days | 63 Days |
Enterprise Value | $2.11B | $45.75B |
Dividend Yield | — | 1.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA Biologics (ADMA) trades at $9.11, up 1.79% on the day, amid a bearish technical outlook but strong analyst support with a 90% buy rating and $18.67 consensus price target. The company maintains robust profitability with a 32.98% net income margin and 41.9% ROE, though recent Q1 and Q2 2026 earnings missed expectations. Positive cash flow growth is projected for 2026, but legal investigations into fiduciary duties present headline risks.
The stock offers significant upside based on analyst targets, driven by solid fundamentals and ASCENIV product growth, but faces near-term pressure from technical weakness and ongoing legal scrutiny. Investors should weigh the high return potential against execution risks and market sentiment challenges.
NRG Energy trades at $103.66, down 2.42% today, with a bearish technical signal despite bullish analyst consensus. The company reported mixed Q2 2026 results with earnings misses but strong revenue growth of 11% year-over-year. Recent developments include a transformative 1.2 GW Texas data center power project and the LS Power acquisition, positioning for long-term growth despite rising interest costs.
The stock presents a compelling value opportunity with a P/S ratio of 0.63 and strong institutional support, though near-term headwinds include elevated debt levels and execution risks from recent acquisitions. Analyst consensus remains bullish with a $202.90 price target representing significant upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
